Viewing Study NCT03635892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-05 @ 3:08 AM
Study NCT ID: NCT03635892
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-22
First Post: 2018-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma View
None Unclassified Renal Cell Carcinoma View
None Papillary Renal Cell Carcinoma View
None Fumarate Hydratase Deficient Renal Cell Carcinoma View
None Succinate Dehydrogenase Deficient Renal Cell Carcinoma View
None Collecting Duct Renal Cell Carcinoma View
None Chromophobe Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nivolumab View
None Cabozantinib View
None 18-254 View